| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2009
|
22.98
|
|
2
|
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2010
|
6.59
|
|
3
|
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2009
|
6.52
|
|
4
|
Combating antimicrobial resistance: policy recommendations to save lives.
|
Clin Infect Dis
|
2011
|
5.58
|
|
5
|
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
|
Pediatrics
|
2004
|
3.71
|
|
6
|
Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.
|
Clin Infect Dis
|
2004
|
3.35
|
|
7
|
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.
|
Surg Infect (Larchmt)
|
2010
|
2.67
|
|
8
|
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.
|
Clin Infect Dis
|
2005
|
2.28
|
|
9
|
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
|
N Engl J Med
|
2011
|
2.18
|
|
10
|
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.
|
Pediatrics
|
2002
|
2.08
|
|
11
|
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
|
Pediatr Infect Dis J
|
2013
|
1.90
|
|
12
|
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.
|
Clin Infect Dis
|
2009
|
1.83
|
|
13
|
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.
|
Pediatrics
|
2010
|
1.77
|
|
14
|
Recurrent systemic pneumococcal disease in children.
|
Pediatr Infect Dis J
|
2007
|
1.65
|
|
15
|
Improved vancomycin dosing in children using area under the curve exposure.
|
Pediatr Infect Dis J
|
2013
|
1.52
|
|
16
|
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features.
|
Pediatr Infect Dis J
|
2004
|
1.52
|
|
17
|
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
|
J Infect Dis
|
2012
|
1.49
|
|
18
|
Best in class: a good principle for antibiotic usage to limit resistance development?
|
J Antimicrob Chemother
|
2007
|
1.44
|
|
19
|
Management of complicated shunt infections: a clinical report.
|
J Neurosurg Pediatr
|
2008
|
1.42
|
|
20
|
Staghorn calculus endotoxin expression in sepsis.
|
Urology
|
2002
|
1.41
|
|
21
|
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
|
Pediatr Infect Dis J
|
2007
|
1.41
|
|
22
|
What is the appropriate treatment course for bacterial arthritis in children?
|
Clin Infect Dis
|
2009
|
1.39
|
|
23
|
Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children.
|
J Am Coll Cardiol
|
2010
|
1.36
|
|
24
|
Six year multicenter surveillance of invasive pneumococcal infections in children.
|
Pediatr Infect Dis J
|
2002
|
1.28
|
|
25
|
The use of systemic and topical fluoroquinolones.
|
Pediatrics
|
2011
|
1.25
|
|
26
|
Evaluation of acoustical conditions for speech communication in working elementary school classrooms.
|
J Acoust Soc Am
|
2008
|
1.22
|
|
27
|
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
|
Emerg Infect Dis
|
2014
|
1.17
|
|
28
|
Streptococcus pneumoniae infections in the neonate.
|
Pediatrics
|
2003
|
1.14
|
|
29
|
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.
|
Clin Infect Dis
|
2008
|
1.11
|
|
30
|
Invasive pneumococcal infections in children with asplenia.
|
Pediatr Infect Dis J
|
2002
|
1.09
|
|
31
|
Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002.
|
Ann Clin Microbiol Antimicrob
|
2004
|
1.07
|
|
32
|
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
|
Pediatr Infect Dis J
|
2010
|
1.04
|
|
33
|
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
|
J Antimicrob Chemother
|
2006
|
1.00
|
|
34
|
Defining pneumonia in critically ill infants and children.
|
Pediatr Crit Care Med
|
2005
|
0.97
|
|
35
|
Quality of care among Aboriginal hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2005
|
0.96
|
|
36
|
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.
|
J Clin Microbiol
|
2011
|
0.95
|
|
37
|
Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections.
|
Pediatr Infect Dis J
|
2011
|
0.93
|
|
38
|
Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza.
|
Curr Med Res Opin
|
2007
|
0.93
|
|
39
|
Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
|
Clin Infect Dis
|
2010
|
0.91
|
|
40
|
Levofloxacin pharmacokinetics in children.
|
J Clin Pharmacol
|
2005
|
0.91
|
|
41
|
Endotoxin content in renal calculi.
|
J Urol
|
2003
|
0.89
|
|
42
|
Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300.
|
BMC Genomics
|
2012
|
0.87
|
|
43
|
Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review.
|
Clin Infect Dis
|
2002
|
0.87
|
|
44
|
Pneumococcal endocarditis in children.
|
Clin Infect Dis
|
2004
|
0.86
|
|
45
|
Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011.
|
J Clin Microbiol
|
2013
|
0.86
|
|
46
|
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
|
Antimicrob Agents Chemother
|
2003
|
0.85
|
|
47
|
Vancomycin monitoring in children using bayesian estimation.
|
Ther Drug Monit
|
2014
|
0.84
|
|
48
|
Pharmacokinetics of gatifloxacin in infants and children.
|
Antimicrob Agents Chemother
|
2005
|
0.83
|
|
49
|
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
|
Antimicrob Agents Chemother
|
2007
|
0.83
|
|
50
|
An artificial neural network approach for predicting architectural speech security.
|
J Acoust Soc Am
|
2005
|
0.82
|
|
51
|
Measures for assessing architectural speech security (privacy) of closed offices and meeting rooms.
|
J Acoust Soc Am
|
2004
|
0.81
|
|
52
|
Linezolid-associated peripheral and optic neuropathy in children.
|
Pediatrics
|
2011
|
0.81
|
|
53
|
Prediction of neurologic sequelae in childhood tuberculous meningitis: a review of 20 cases and proposal of a novel scoring system.
|
Pediatr Infect Dis J
|
2005
|
0.81
|
|
54
|
Pediatric anthrax clinical management.
|
Pediatrics
|
2014
|
0.81
|
|
55
|
Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics.
|
Semin Pediatr Infect Dis
|
2004
|
0.80
|
|
56
|
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.
|
Pediatr Infect Dis J
|
2016
|
0.79
|
|
57
|
Exchange blood transfusion in the management of severe pertussis in young infants.
|
Pediatr Infect Dis J
|
2013
|
0.79
|
|
58
|
Population pharmacokinetic model for gatifloxacin in pediatric patients.
|
Antimicrob Agents Chemother
|
2007
|
0.78
|
|
59
|
A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis.
|
J Pediatr Orthop
|
2009
|
0.78
|
|
60
|
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.
|
Pediatr Infect Dis J
|
2015
|
0.78
|
|
61
|
Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
|
Pediatr Neurosurg
|
2008
|
0.78
|
|
62
|
Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics.
|
Paediatr Drugs
|
2007
|
0.77
|
|
63
|
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
|
Pediatr Infect Dis J
|
2016
|
0.77
|
|
64
|
Pediatric anthrax clinical management: executive summary.
|
Pediatrics
|
2014
|
0.77
|
|
65
|
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.
|
Pediatr Infect Dis J
|
2016
|
0.76
|
|
66
|
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure.
|
Pediatr Infect Dis J
|
2016
|
0.76
|
|
67
|
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
|
68
|
Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
|
Pediatr Infect Dis J
|
2003
|
0.75
|
|
69
|
Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
|
Pediatr Crit Care Med
|
2017
|
0.75
|
|
70
|
Editor's note.
|
Pediatr Infect Dis J
|
2013
|
0.75
|
|
71
|
Guidelines for the selection of antibacterial therapy in children.
|
Pediatr Clin North Am
|
2005
|
0.75
|
|
72
|
Using listening difficulty ratings of conditions for speech communication in rooms.
|
J Acoust Soc Am
|
2005
|
0.75
|
|
73
|
An Observational Study of Severe Pertussis in 100 Infants ≤ 120 Days of Age.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
|
74
|
General method of preparation of mesoporous M/Si3N4 nano-composites via a non-aqueous sol-gel route.
|
Chem Commun (Camb)
|
2005
|
0.75
|
|
75
|
Preparation of a mesoporous silicon boron nitride via a non-aqueous sol-gel route.
|
Chem Commun (Camb)
|
2003
|
0.75
|
|
76
|
Transmission of meropenem in breast milk.
|
Pediatr Infect Dis J
|
2012
|
0.75
|